Consequently, a protective genetic signal observed in blood may not translate into the same expression pattern within tumor tissues, which could account for the opposing SPX trends identified in ovarian and cervical cancers.Similar tissue-specific regulatory phenomena have also been reported in tumor suppressor genes, such as TP53 [25]. The gene discussed is SPX; the disease is cervical carcinoma.